Aripiprazole maintenance increases smoked cocaine self-administration in humans

Psychopharmacology

Volumn 216, Issue 3, 2011, Pages 379-387

  Haney, Margaret ^a   Rubin, Eric ^a   Foltin, Richard W ^a  

^a New York State Psychiatric Institute ^*  (United States)

Author keywords

Addiction; Antipsychotic; Cocaine

Indexed keywords

ARIPIPRAZOLE; COCAINE; PLACEBO;

ADULT; ARTICLE; CARDIOVASCULAR EFFECT; CLINICAL ARTICLE; COCAINE DEPENDENCE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG HALF LIFE; DRUG SEEKING BEHAVIOR; DRUG SELF ADMINISTRATION; EVENING DOSAGE; HUMAN; MAINTENANCE THERAPY; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; SMOKING; STEADY STATE; TREATMENT DURATION; TREATMENT RESPONSE; VOLUNTEER; WITHDRAWAL SYNDROME;

ADULT; BLOOD PRESSURE; COCAINE; COCAINE-RELATED DISORDERS; DOPAMINE AGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROCARDIOGRAPHY; HEART RATE; HUMANS; MALE; PIPERAZINES; QUINOLONES; REINFORCEMENT SCHEDULE; SELF ADMINISTRATION; SMOKE; TOKEN ECONOMY;

EID: 79961170462     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-011-2231-6     Document Type: Article

References (44)

1. L Amato S Minozzi PP Pani M Davoli 2010 Antipsychotic medications for cocaine dependence (Review) Cochrane Libr 3 1 37
2. TP Beresford L Clapp B Martin JL Wiberg J Alfers HF Beresford 2005 Aripiprazole in schizophrenia with cocaine dependence: a pilot study J Clin Psychopharmacol 25 363 366 16012280 10.1097/01.jcp.0000169419.38899.5b 1:CAS:528:DC%2BD2MXmtVahsro%3D (Pubitemid 41060257)
3. 2 partial agonist aripiprazole (Abilify®) Exp Clin Psychopharmacol 16 475 483 19086768 10.1037/a0014398 1:CAS:528:DC%2BD1MXmt1Ortg%3D%3D
4. RM Berman RN Marcus R Swanink R McQuade WH Carson PK Corey-Lisle A Khan 2007 The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a multicenter, randomized, double-blind, placebo-controlled study J Clin Psychiatr 68 843 853 10.4088/JCP.v68n0604 1:CAS:528: DC%2BD2sXot1eitrY%3D (Pubitemid 47015482)
5. ES Brown J Jeffress JD Liggin M Garza L Beard 2005 Switching outpatients with bipolar or schizoaffective disorders and substance abuse from their current antipsychotic to aripiprazole J Clin Psychiatr 66 756 760 10.4088/JCP.v66n0613 (Pubitemid 40942423)
6. K Cahill L Stead T Lancaster 2009 A preliminary benefit-risk assessment of varenicline in smoking cessation Drug Saf 2 119 135 10.2165/00002018- 200932020-00005
7. SD Comer MA Sullivan E Yu JL Rothenberg HD Kleber K Kampman C Dackis CP O'Brien 2006 Injectable, sustained-release naltrexone for the treatment of opioid dependence: a randomized, placebo-controlled trial Arch Gen Psychiatr 63 210 218 16461865 10.1001/archpsyc.63.2.210 1:CAS:528:DC%2BD28XhslWku7g%3D (Pubitemid 43213883)
8. P Crits-Christoph L Siqueland J Blaine A Frank L Luborsky LS Onken LR Muenz ME Thase RD Weiss DR Gastfriend GE Woody JP Barber SF Butler D Daley I Salloum S Bishop LM Najavits J Lis D Mercer ML Griffin K Moras AT Beck 1999 Psychosocial treatments for cocaine dependence: National Institute on Drug Abuse Collaborative Cocaine Treatment Study Arch Gen Psychiatr 56 493 502 10359461 10.1001/archpsyc.56.6.493 1:STN:280:DyaK1M3os1Shsg%3D%3D (Pubitemid 29304640)
9. L Dutra G Stathopoulou SL Basden TM Leyro MB Powers MW Otto 2008 A meta-analytic review of psychosocial interventions for substance abuse use disorders Am J Psychiatr 165 179 187 18198270 10.1176/appi.ajp.2007.06111851 (Pubitemid 351704516)
10. Evans SM, Haney M, Foltin RW (2002) The effects of smoked cocaine during the follicular and luteal phases of the menstrual cycle in women. Psychopharmacology (Berl) 159:397-406 (Pubitemid 34143364)
11. MW Feltenstein CA Altar RE See 2007 Aripiprazole blocks reinstatement of cocaine seeking in an animal model of relapse Biol Psychiatr 61 582 590 10.1016/j.biopsych.2006.04.010 1:CAS:528:DC%2BD2sXhvVynu74%3D (Pubitemid 46328850)
12. MW Feltenstein PH Do RE See 2009 Repeated aripiprazole administration attenuates cocaine seeking in a rat model of relapse Psychopharmacology 207 401 411 19779699 10.1007/s00213-009-1671-8 1:CAS:528:DC%2BD1MXhtFOhsrfL
13. JA Grabowski J Shearer J Merrill SS Negus 2004 Agonist-like, replacement pharmacotherapy for stimulant abuse and dependence Addict Behav 29 1439 1464 15345275 10.1016/j.addbeh.2004.06.018 (Pubitemid 39172183)
14. M Haney R Spealman 2008 Controversies in translational research: drug self-administration Psychopharmacology 199 403 419 18283437 10.1007/s00213-008- 1079-x 1:CAS:528:DC%2BD1cXotVyrsbg%3D
15. M Haney AS Ward RW Foltin MW Fischman 2001 Effects of ecopipam, a selective dopamine D1 antagonist, on smoked cocaine self-administration by humans Psychopharmacology 155 330 337 11441422 10.1007/s002130100725 1:CAS:528:DC%2BD3MXkvFShurw%3D (Pubitemid 32523103)
16. M Haney EW Gunderson H Jiang ED Collins RW Foltin 2010 Cocaine-specific antibodies blunt the subjective effects of smoked cocaine in humans Biol Psychiatr 67 59 65 10.1016/j.biopsych.2009.08.031 1:CAS:528:DC%2BD1MXhsFGrsbnI
17. LL Howell HL Kimmel 2008 Monoamine transporters and psychostimulant addition Biochem Pharmacol 75 196 217 17825265 10.1016/j.bcp.2007.08.003 1:CAS:528:DC%2BD2sXhsVCksLjJ (Pubitemid 350235397)
18. T Inoue M Domae K Yamada T Furukawa 1996 Effects of the novel antipsychotic agent 7-(4-[4-(2, 3-dichlorophenyl)-1-piperazinyl]butyloxy)-3, 4-dihydro-2(1H)-quinolinone (OPC-14597) on prolactin release from the rat anterior pituitary gland J Pharmacol Exp Ther 277 137 143 8613910 1:CAS:528:DyaK28XitlCmtr0%3D
19. RE Johnson MA Chutuape EC Strain SL Walsh ML Stitzer GE Bigelow 2000 A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence N Engl J Med 343 1290 1297 11058673 10.1056/NEJM200011023431802 1:CAS:528:DC%2BD3cXotV2iurg%3D
20. PE Keck R Marcus S Tourkodimitris M Ali A Liebeskind A Saha G Ingentio 2003 A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania Am J Psychiatr 160 1651 1658 12944341 10.1176/appi.ajp.160.9.1651 (Pubitemid 41079552)
21. CP Lawler C Prioleau MM Lewis C Mak D Jiang JA Schetz AM Gonzalez DR Sibley RB Mailman 1999 Interactions of the novel antipsychotic aripiprazole (OPC-14597) with dopamine and serotonin receptor subtypes Neuropsychopharmacology 20 612 627 10327430 10.1016/S0893-133X(98)00099-2 1:CAS:528:DyaK1MXjsVamu7c%3D (Pubitemid 29189265)
22. JA Lieberman 2004 Dopamine partial agonists: a new class of antipsychotic CNS Drugs 18 251 267 15015905 10.2165/00023210-200418040-00005 1:CAS:528:DC%2BD2cXjtl2gsrk%3D (Pubitemid 38393435)
23. JA Lile WW Stoops AR Vansickel PE Glaser LR Hays CR Rush 2005 Aripiprazole attenuates the discriminative-stimulus and subject-rated effects of D-amphetamine in humans Neuropsychopharmacology 30 2103 2114 15988473 10.1038/sj.npp.1300803 1:CAS:528:DC%2BD2MXhtFWlt7jL (Pubitemid 43093509)
24. JA Lile WW Stoops LR Hays CR Rush 2008 The safety, tolerability, and subject-rated effects of acute intranasal cocaine administration during aripiprazole maintenance II: increased aripipirazole dose and maintenance period Am J Drug Alcohol Abuse 34 721 729 18855244 10.1080/00952990802308262
25. Lile JA, Stoops WW, Glaser PE, Hays LR, Rush CR (2011). Discriminative stimulus, subject-rated and cardiovascular effects of cocaine alone and in combination with aripiprazole in humans. J Psychopharmacology October 15 (in press)
26. D Mamo A Graff R Mizrahi CM Shammi F Romeyer S Kapur 2007 Differential effects of aripiprazole on D(2), 5-HT(2), and 5-HT(1A) receptor occupancy in patients with schizophrenia: a triple tracer PET study Am J Psychiatr 164 1411 1417 17728427 10.1176/appi.ajp.2007.06091479 (Pubitemid 47461142)
27. BA Martell FM Orson J Poling E Mitchell RD Rossen T Gardner TR Kosten 2009 Cocaine vaccine for the treatment of cocaine dependence in methadone-maintained patients: a randomized, double-blind, placebo-controlled efficacy trial Arch Gen Psychiatr 66 1116 1123 19805702 10.1001/ archgenpsychiatry.2009.128 1:CAS:528:DC%2BD1MXhtleiurnM
28. D Martinez R Narendran RW Foltin M Slifstein DR Hwang A Broft Y Huang TB Cooper MW Fischman HD Kleber M Laruelle 2007 Amphetamine-induced dopamine release: markedly blunted in cocaine dependence and predictive of the choice to self-administer cocaine Am J Psychiatr 164 622 629 17403976 10.1176/appi.ajp. 164.4.622 (Pubitemid 46650194)
29. D Martinez K Greene A Broft D Kumar F Liu R Narendran M Slifstein R Van Heertum HD Kleber 2009 Lower level of endogenous dopamine in patients with cocaine dependence: findings from PET imaging of D(2)/D(3) receptors following acute dopamine depletion Am J Psychiatr 166 1170 1177 19723785 10.1176/appi.ajp.2009.08121801
30. JW Newcomer 2005 Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review CNS Drugs 19 Suppl 1 1 93 15998156 1:CAS:528:DC%2BD2MXltFCqu74%3D (Pubitemid 40677047)
31. TF Newton MS Reid R De La Garza JJ Mahoney A Abad R Condos J Palamar PN Halkitis J Mojisak A Anderson SH Li A Elkashef 2008 Evaluation of subjective effects of aripiprazole and methamphetamine in methamphetamine-dependent volunteers Int J Neuropsychopharmacol 11 1037 1045 18664303 10.1017/ S1461145708009097 1:CAS:528:DC%2BD1cXhtlens73N
32. L Owen RN Sikich Marcus, et al. 2009 Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder Pediatrics 124 1533 1540 19948625 10.1542/peds.2008-3782
33. DM Platt JS Rodefer JK Rowlett 2002 Suppression of cocaine- and food-maintained behavior by the D2-like receptor partial agonist terguride in squirrel monkeys Psychopharmacology (Berl) 166 298 305
34. L Pulvirenti GF Koob 2002 Being partial to psychostimulant addiction therapy Trends in Pharmacol Sci 23 151 153 10.1016/S0165-6147(00)01991-X 1:CAS:528:DC%2BD38XisV2hur4%3D (Pubitemid 34270586)
35. G Sørensen TN Sager JH Petersen LT Brennum P Thøgersen C Hee Bengtsen M Thomsen G Wörtwein A Fink-Jensen DP Woldbye 2008 Aripiprazole blocks acute self-administration of cocaine and is not self-administered in mice Psychopharmacology 199 37 46 18481046 10.1007/s00213-008-1069-z
36. WW Stoops 2006 Aripiprazole as a potential pharmacotherapy for stimulant dependence: human laboratory studies with d-amphetamine Exp Clin Psychopharmacol 4 413 421 (Pubitemid 44789962)
37. WW Stoops JA Lile MR Lofwall CR Rush 2007 The safety, tolerability, and subject-rated effects of acute intranasal cocaine administration during aripiprazole maintenance Am J Drug Alcohol Abuse 33 769 776 17994473 10.1080/00952990701651556 (Pubitemid 350125771)
38. M Thomsen A Fink-Jensen DP Woldbye G Wörtwein TN Sager R Holm LM Pepe SB Caine 2008 Effects of acute and chronic aripiprazole treatment on choice between cocaine self-administration and food under a concurrent schedule of reinforcement in rats Psychopharmacology 201 43 53 18612628 10.1007/s00213-008- 1245-1 1:CAS:528:DC%2BD1cXht1GrurfO
39. J Tiihonen K Kuoppasalmi J Föhr P Tuomola O Kuikanmäki H Vorma P Sokero J Haukka E Meririnne 2007 A comparison of aripiprazole, methylphenidate, and placebo for amphetamine dependence Am J Psychiatr 164 160 162 17202560 10.1176/appi.ajp.164.1.160 (Pubitemid 46154797)
40. FJ Vocci WW Ling 2005 Medications development: successes and challenges Pharmacol Ther 108 94 108 16083966 10.1016/j.pharmthera.2005.06.010 1:CAS:528:DC%2BD2MXhtVartr3E (Pubitemid 41377122)
41. ND Volkow GJ Wang MW Fischman RW Foltin JS Fowler NN Abumrad S Vitkun J Logan N Pappas R Hitzermann CE Shea 1997 Relationship between subjective effects of cocaine and dopamine transporter occupancy Nature 386 827 830 9126740 10.1038/386827a0 1:CAS:528:DyaK2sXivVGjtbw%3D (Pubitemid 27181255)
42. ND Volkow JS Fowler GJ Wang JM Swanson 2004 Dopamine in drug abuse and addiction: results from imaging studies and treatment implications Mol Psychiatr 9 557 569 10.1038/sj.mp.4001507 1:CAS:528:DC%2BD2cXkt1Gnt7Y%3D (Pubitemid 38850435)
43. S Wee Z Wang WL Woolverton L Pulvirenti GF Koob 2007 Effect of aripiprazole, a partial dopamine D2 receptor agonist, on increased rate of methamphetamine self-administration in rats with prolonged session duration Neuropsychopharmacology 32 2238 2247 17327886 10.1038/sj.npp.1301353 1:CAS:528:DC%2BD2sXhtVCisbjM (Pubitemid 47417701)
44. F Yokoi G Gründer K Biziere M Stephane AS Dogan RF Dannals H Ravert A Suri S Bramer DF Wong 2002 Dopamine D2 and D3 receptor occupancy in normal humans treated with the antipsychotic drug aripiprazole (OPC 14597): a study using positron emission tomography and [11C]raclopride Neuropsychopharmacology 27 248 259 12093598 10.1016/S0893-133X(02)00304-4 1:CAS:528:DC%2BD38XkvFyqt74%3D (Pubitemid 34692591)